TLSI
TLSI
NASDAQ · Biotechnology

Trisalus Life Sciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$4.34
-0.27 (-5.86%)
As of Sep 27, 10:41 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target -0.2% upside
Low Target $2.61
Average Target $4.33
High Target $5.56
Current Price $4.34
Current
$4.34
Target
$4.33
$2.61 $4.33 avg $5.56
Scenario Analysis
Bear Case
$2.61
-39.9%
Low target
Base Case
$4.33
-0.2%
Avg target
Bull Case
$5.56
+28.1%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$7.95
-45.4% from high
52-Week Low
$2.20
+97.3% from low
Target vs 52W High
$4.33
-45.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.2%